Versartis, Inc. (VSAR): Price and Financial Metrics


Versartis, Inc. (VSAR): $1.19

-0.02 (-1.65%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VSAR to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

VSAR Stock Price Chart Interactive Chart >

Price chart for VSAR

VSAR Price/Volume Stats

Current price $1.19 52-week high $2.76
Prev. close $1.21 52-week low $1.14
Day low $1.18 Volume 349,900
Day high $1.30 Avg. volume 479,428
50-day MA $1.56 Dividend yield N/A
200-day MA $1.76 Market Cap 43.13M

Versartis, Inc. (VSAR) Company Bio


Versartis is an endocrine-focused biopharmaceutical company initially developing somavaratan (VRS-317), a novel, long-acting form of recombinant human growth hormone for the treatment of growth hormone deficiency (GHD). The company was founded in 2008 and is based in Menlo Park, California.


VSAR Latest News Stream


Event/Time News Detail
Loading, please wait...

VSAR Latest Social Stream


Loading social stream, please wait...

View Full VSAR Social Stream

VSAR Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4935 seconds.